Abstract:Dynamic cerebral blood flow (CBF) regulation via neurovascular coupling (NVC) is essential to meet localized brain oxygen and nutrient demands. Cerebral microvascular dysfunction contributes to the pathogenesis of many types of dementias. Previous studies suggest that oxidative stress play a critical role in endothelial disfunction, cerebral microvascular impairments, and blunted NVC responses. Increased reactive oxidative species (ROS), inflammatory cytokines, and decreased brain blood flow contribute to the progression of both vascular contributions to cognitive impairment and dementia (VCID) and Alzheimer's disease related dementia (ADRD).Our novel synthetic glycosylated Angiotensin-(1-7) derivative, PNA5, reverses cognitive deficits, inhibits brain ROS and inflammatory cytokine production, and limits microglial activation in our preclinical model of heart failure (HF)-induced VCID. We hypothesize that heart failure (HF) impairs cerebral vascular dilation and NVC, and that treatment with extended release PNA5 (PNA5ER) will improved cerebral vascular dilation and NVC. Adult male C57BL/6J mice (6-10/group) were subjected to HF via left anterior artery ligation or sham surgery 5 weeks prior to treatment with either 1) Vehicle (DMSO) or 2) 1.5mg PNA5ER (30uL of 50 mg/mL). Treatments were delivered subcutaneously at time= 3 weeks and again at t= 1 week prior to vascular evaluation and sacrifice. NVC was assessed using laser speckle imaging. Basal cerebral perfusion and NVC after somatosensory stimulation were assessed by laser speckle contrast imaging. NVC was calculated as a percent change in perfusion from baseline induced by stimulation. Basilar arteries were mounted on a wire myograph to assess cerebral vascular function. HF mice receiving vehicle treatment (n=2, mean= 4.41, Std Deviation=2.32) trend to have decreased NVC response compared to Sham (n=5, mean= 13.63, Std Deviation= 10.35), which may be rescued by PNA5ER (n=3, mean= 10.32, Std Deviation= 4.499). Endothelium-dependent dilation of basilar arteries, induced by cumulative concentrations of NS309 and 2-Methylthio-ADP, was impaired in HF compared to Sham mice; PNA5ER improved vasodilatory responses in the basilar artery.Our preliminary data suggest that PNA5ER protects against NVC impairments and improves basilar artery vasodilation in mice with HF-induced VCID, thereby potentially increasing the ability of the vasculature to meet the localized metabolic demands of the brain. Supported by NIA This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Resveratrol Mitigates Cognitive Impairments and Cholinergic Cell Loss in the Medial Septum in a Mouse Model of Gradual Cerebral Hypoperfusion

Resveratrol Attenuates Subacute Systemic Inflammation-Induced Spatial Memory Impairment Via Inhibition of Astrocyte Activation and Enhancement of Synaptophysin Expression in the Hippocampus.

(-)-SCR1693 Protects Against Memory Impairment and Hippocampal Damage in a Chronic Cerebral Hypoperfusion Rat Model

Chronic resveratrol administration reduces oxidative stress and brain cell loss and improves memory of recognition in old rats

Resveratrol Reverses the Synaptic Plasticity Deficits in a Chronic Cerebral Hypoperfusion Rat Model

FTY720 Prevents Spatial Memory Impairment in a Rat Model of Chronic Cerebral Hypoperfusion via a SIRT3-Independent Pathway

Resveratrol Activates Autophagy via the AKT/mTOR Signaling Pathway to Improve Cognitive Dysfunction in Rats With Chronic Cerebral Hypoperfusion

Preservation of spatial memory and neuroprotection by the fatty acid amide hydrolase inhibitor URB597 in a rat model of vascular dementia

Abstract TMP109: Isosorbide Mononitrate And Cilostazol Treatment Prevents Temporal Changes In The Brain Microstructure Of Diabetic Rats Following Microemboli Injection: Relevance To Vascular Cognitive Impairment And Dementia (VCID)

Intermittent Fasting Pretreatment Prevents Cognitive Impairment in a Rat Model of Chronic Cerebral Hypoperfusion

Mumefural Improves Recognition Memory and Alters ERK-CREB-BDNF Signaling in a Mouse Model of Chronic Cerebral Hypoperfusion

Protective effect of resveratrol on chronic cerebral hypoperfusion-induced cognitive impairment in rats

Intermittent Fasting Mitigates Vascular and Neuronal Pathologies in a Mouse Model of Vascular Dementia

A novel therapeutic Ang(1-7) analogue improves neurovascular function in mice with vascular contributions to cognitive impairment and dementia

Resveratrol Attenuates Brain Damage in Permanent Focal Cerebral Ischemia Via Activation of PI3K/Akt Signaling Pathway in Rats

Time-Restricted Feeding Mitigates Age-Related Cognitive Decline: Impacts on Neurovascular Coupling and Blood-Brain Barrier

Resveratrol reduces inflammatory response and detrimental effects in chronic cerebral hypoperfusion by down-regulating stimulator of interferon genes/TANK-binding kinase 1/interferon regulatory factor 3 signaling

HUCBC Treatment Improves Cognitive Outcome in Rats With Vascular Dementia

A Dietary Polyphenol Resveratrol Acts to Provide Neuroprotection in Recurrent Stroke Models by Regulating AMPK and SIRT1 Signaling, Thereby Reducing Energy Requirements During Ischemia

Metformin, Rapamycin, or Nicotinamide Mononucleotide Pretreatment Attenuate Cognitive Impairment After Cerebral Hypoperfusion by Inhibiting Microglial Phagocytosis

Resveratrol Attenuated Manganese-Induced Learning and Memory Impairments in Mice Through PGC-1Alpha-Mediated Autophagy and Microglial M1/M2 Polarization